<prompt> Myopathy is seen in all exceptMyopathy is seen in all exceptX-linked hypophatemic ricketsOncogenic osteomalaciaNutritional osteomalacia  <response>: .Myopathies in systemic disease results from several different disease processes including endocrine, inflammatory, paraneoplastic, infectious, drug- and toxin-induced, critical illness myopathy, metabolic, collagen related, and myopathies with other systemic disorders. Patients with systemic myopathies often present acutely or sub acutely. On the other hand, familial myopathies or dystrophies generally present in a chronic fashion with exceptions of metabolic myopathies where symptoms on occasion can be precipitated acutely. Most of the inflammatory myopathies can have a chance association with malignant lesion; the incidence appears to be specifically increased only in patients with dermatomyositis. There are many types of myopathy. ICD-10codes are provided here where available. Inherited formsEdit G71.0 Dystrophies or muscular dystrophies are a subgroup of myopathies characterized by muscle degeneration and regeneration. Clinically, muscular dystrophies are typically progressive, because the muscles ability to regenerate is eventually lost, leading to progressive weakness, often leading to use of a wheelchair, and eventually death, usually related to respiratory weakness. G71.1 Myotonia Neuromyotonia G71.2 The congenital myopathies do not show evidence for either a progressive dystrophic process i.e., muscle death or inflammation, but instead characteristic microscopic changes are seen in association with reduced contractile ability of the muscles. Congenital myopathies include, but are not limited to: G71.2 nemaline myopathycharacterized by presence of nemaline rods in the muscle, G71.2 multiminicore myopathycharacterized by multiple small cores or areas of disruption in the muscle fibers, G71.2 centronuclear myopathy or myotubular myopathy in which the nuclei are abnormally found in the center of the muscle fibers, a rare muscle wasting disorder G71.3 Mitochondrial myopathies, which are due to defects in mitochondria, which provide a critical source of energy for muscle G72.3 Familial periodic paralysis G72.4 Inflammatory myopathies, which are caused by problems with the immune system attacking components of the muscle, leading to signs of inflammationin the muscle G73.6 Metabolic myopathies, which result from defects in biochemical metabolism that primarily affect muscle G73.6E74.0 Glycogen storage diseases, which may affect muscle G73.6E75 Lipid storage disorder G72.89 Other myopathies Brody myopathy Congenital myopathy with abnormal subcellular organelles Fingerprint myopathy Inclusion body myopathy 2 Megaconial myopathy Myofibrillar myopathy Rimmed vacuolar myopathy AcquiredEdit G72.0 - G72.2 External substance induced myopathy G72.0 Drug-induced myopathy Glucocoicoid myopathy is caused by this class of steroids increasing the breakdown of the muscle proteins leading to muscle atrophy. G72.1 Alcoholic myopathy G72.2 Myopathy due to other toxic agents - including atypical myopathy in horses caused by toxins in Sycamore seeds and seedlings. M33.0-M33.1 Dermatomyositis produces muscle weakness and skin changes. The skin rash is reddish and most commonly occurs on the face, especially around the eyes, and over the knuckles and elbows. Ragged nail folds with visible capillaries can be present. It can often be treated by drugs like coicosteroids or immunosuppressants. M33.2 Polymyositis produces muscle weakness. It can often be treated by drugs like coicosteroids or immunosuppressants. Inclusion body myositis is a slowly progressive disease that produces weakness of hand grip and straightening of the knees. No effective treatment is known. M61 Myositis ossificans M62.89 Rhabdomyolysis and R82.1 myoglobinurias 